SMS Lifesciences India Q4FY21 consolidated net profit ups to Rs. 5.05 Cr
Chemical

SMS Lifesciences India Q4FY21 consolidated net profit ups to Rs. 5.05 Cr

The company reported total income of Rs.267.37 crores during the 12 months period ended March 31, 2021

  • By ICN Bureau | June 19, 2021

SMS Lifesciences India has reported total income of Rs.83.78 crores during the period ended March 31, 2021 as compared to Rs.67.18 crores during the period ended December 31, 2020. The company reported total income of Rs.46.85 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.5.05 crores for the period ended March 31, 2021 as against net profit of Rs.2.69 crores for the period ended December 31, 2020. The company posted net profit of Rs.1.57 crores for the period ended March 31, 2020.

SMS Lifesciences India has reported total income of Rs.267.37 crores during the 12 months period ended March 31, 2021 as compared to Rs.263.06 crores during the 12 months period ended March 31, 2020.

The company has posted net profit of Rs.13.55 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.10.18 crores for the 12 months period ended March 31, 2020.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.